您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION INCLUDING AN SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND ANY ADDITIONAL ANTIDIABETIC AGENT AND ITS APPLICATIONS
专利权人:
Boehringer Ingelheim International GmbH
发明人:
EICKELMANN, Peter,MARK, Michael,SEMAN, Leo John,THOMAS, Leo,BROEDL, Uli,GREMPLER, Rolf
申请号:
DK10703288
公开号:
DK2395983T3
申请日:
2010.02.11
申请国别(地区):
DK
年份:
2020
代理人:
摘要:
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充